After antigen-presenting cells such as DCs are activated, they present tumour antigens to CD4+ T cells or CD8+ T cells, which are activated and proliferate into tumour-specific CTLs, enhancing the cytotoxic effects of the CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.